Clinical Trial Update: Plasma P-tau2017 and Quantitative Amyloid PET Imaging [Phase 1]

View source ↗

Summary

Phase 1 study update evaluating plasma P-tau2017 and quantitative amyloid PET imaging in Alzheimer disease. The trial has completed and provided biomarker imagi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Invicro | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED